Grey Wolf Health Corp.
WOLF.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.25% | 28.07% | 30.88% | 23.96% | 16.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.25% | 28.07% | 30.88% | 23.96% | 16.21% |
| Cost of Revenue | 18.93% | 22.71% | 25.45% | 19.21% | 11.72% |
| Gross Profit | 23.33% | 33.08% | 36.03% | 28.47% | 20.56% |
| SG&A Expenses | 18.32% | 20.75% | 19.44% | 19.78% | 13.09% |
| Depreciation & Amortization | 17.22% | 34.64% | 68.22% | 64.50% | 40.34% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.58% | 22.51% | 24.81% | 21.44% | 13.59% |
| Operating Income | 48.31% | 91.90% | 104.57% | 53.73% | 51.44% |
| Income Before Tax | 57.01% | 95.09% | 67.02% | -2.92% | 12.65% |
| Income Tax Expenses | 16.63% | 14.57% | 3.57% | 8.04% | 15.28% |
| Earnings from Continuing Operations | 91.07% | 184.13% | 127.62% | -10.74% | 10.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.07% | 184.13% | 127.62% | -10.74% | 10.57% |
| EBIT | 48.31% | 91.90% | 104.57% | 53.73% | 51.44% |
| EBITDA | 34.83% | 70.30% | 90.87% | 63.35% | 53.51% |
| EPS Basic | 128.37% | 220.34% | 149.30% | -34.12% | -11.88% |
| Normalized Basic EPS | 67.03% | 94.86% | 64.58% | -19.57% | -2.15% |
| EPS Diluted | 185.32% | 326.74% | 212.73% | -47.80% | -29.22% |
| Normalized Diluted EPS | 64.29% | 92.00% | 62.50% | -21.30% | -2.15% |
| Average Basic Shares Outstanding | 9.29% | 11.87% | 14.69% | 5.06% | 2.46% |
| Average Diluted Shares Outstanding | 10.52% | 13.11% | 16.63% | 6.94% | 3.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |